HLS Therapeutics Inc T.HLS

Alternate Symbol(s): HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.

TSX:HLS - Post by User

HLS Therapeutics Inc

Bullboard Posts

Comment by Pat123on Sep 03, 2015 9:53pm

160 Views

Post# 24077581

RE:RE:RE:Dutch Auction

Management in this company is really impressive. Always doing the right thing for increasing value.

They will grab share at below cash. I'm definitely not tendering my shares. First, the price could be north of $3 by the end of October with a GM settlement. In addition, I don't want to pay taxes on dividend. The tax impact of this offerring is not favorable for many investors.

Finally, no directors/insiders are tendering their shares (excepted for 105k shares). Why should we?

I'll be surprise if they reach the $15M.

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments